Previous studies have reported expression levels of BIRC5 (Jin et al., 2015), KITLG (Hu et al., 2021), SPP1 (Long et al., 2018), and SHC1 (He et al., 2019) could serve as biomarkers for predicting prognosis in HCC. Here, SPP1 is linked to hepatocellular carcinoma.